|
|
Volumn 30, Issue 5, 2012, Pages 746-747
|
|
Commentary on "Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: A meta-analysis of randomized trials." Nguyen PL, Je Y, Schutz FA, Hoffman KE, Hu JC, Parekh A, Beckman JA, Choueiri TK, Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GONADORELIN AGONIST;
ANDROGEN DEPRIVATION THERAPY;
CANCER MORTALITY;
CANCER PATIENT;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR MORTALITY;
COCHRANE LIBRARY;
DISEASE ASSOCIATION;
EMBASE;
HEART DEATH;
HUMAN;
MEDLINE;
META ANALYSIS;
MORTALITY;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATE CANCER SPECIFIC MORTALITY;
RECURRENT DISEASE;
RISK ASSESSMENT;
SHORT SURVEY;
SYSTEMATIC REVIEW;
|
|
EID: 84866767566
PISSN: 10781439
EISSN: 18732496
Source Type: Journal
DOI: 10.1016/j.urolonc.2012.06.007 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|
